In the dean's office.
Looking at the surprised expression on Tian Liangwei's face, Xu Yun hesitated for a few seconds and decided to keep a low profile:
"That's right, initially, I just planned to attempt a breakthrough in the fourth-generation Imidacloprid. But by coincidence, I suddenly thought of a situation where two males would still need a female for a second round of transmission, which might lead to a halved coverage rate.
Moreover, I wasn't very satisfied with the insecticidal efficiency of the fourth generation, so I thought about attempting to tackle the fifth generation, since the most critical fourth-generation barrier had already been overcome.
Unexpectedly, after two days of divided research, breakthroughs were achieved on both sides. The next step is simply to dock and synthesize the attractants."
